AGUENNOUZ, M'hammed
 Distribuzione geografica
Continente #
NA - Nord America 5.935
EU - Europa 5.890
AS - Asia 1.903
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 8
AF - Africa 3
Totale 13.762
Nazione #
US - Stati Uniti d'America 5.892
IE - Irlanda 1.592
SE - Svezia 1.350
IT - Italia 1.028
CN - Cina 968
SG - Singapore 765
DE - Germania 545
UA - Ucraina 481
FI - Finlandia 292
GB - Regno Unito 178
PL - Polonia 134
FR - Francia 107
IN - India 98
BE - Belgio 73
CA - Canada 29
CZ - Repubblica Ceca 24
VN - Vietnam 24
AT - Austria 23
RU - Federazione Russa 20
NL - Olanda 16
MX - Messico 14
ID - Indonesia 13
IR - Iran 12
EU - Europa 8
CL - Cile 7
AU - Australia 5
TW - Taiwan 5
LT - Lituania 4
BG - Bulgaria 3
CH - Svizzera 3
CO - Colombia 3
GR - Grecia 3
HK - Hong Kong 3
KR - Corea 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
ES - Italia 2
IL - Israele 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
BR - Brasile 1
EG - Egitto 1
HR - Croazia 1
IQ - Iraq 1
IS - Islanda 1
JP - Giappone 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 13.762
Città #
Dublin 1.591
Chandler 1.111
Jacksonville 1.058
Nyköping 838
Singapore 621
Beijing 397
Messina 315
Ashburn 307
Princeton 299
Medford 274
Ann Arbor 243
Cambridge 243
Des Moines 209
Dearborn 172
Warsaw 126
Boardman 125
Wilmington 79
Jinan 77
Shenyang 76
New York 68
San Mateo 66
Brussels 65
Woodbridge 63
Lancaster 60
Munich 53
Nanjing 48
Los Angeles 47
Hyderabad 46
Bremen 45
Helsinki 45
Rome 44
Tianjin 38
Hebei 36
Pune 36
Ningbo 31
Zhengzhou 28
Taizhou 27
Caltagirone 26
Haikou 26
Hangzhou 25
Dong Ket 24
Norwalk 24
Seattle 24
Houston 22
Vienna 22
Falls Church 21
Brno 20
Milan 20
Catania 18
Ottawa 18
Palo Del Colle 18
Nürnberg 17
Washington 16
Augusta 15
Guangzhou 15
Fuzhou 13
Jakarta 13
Auburn Hills 12
Nanchang 12
Changsha 11
Mascali 11
Taiyuan 11
Ardabil 9
Bari 9
Guadalupe 9
Leawood 9
Rovereto 8
Toronto 8
Monmouth Junction 7
Waanrode 7
Catanzaro 6
Jiaxing 6
Lanzhou 6
London 6
Taranto 6
Torino 6
Ciudad Benito Juárez 5
Gela 5
Genova 5
Hefei 5
Lappeenranta 5
Monopoli 5
Mumbai 5
Paris 5
Shanghai 5
Bologna 4
Chambéry 4
Fairfield 4
Padova 4
Redwood City 4
San Jose 4
Santa Clara 4
Amsterdam 3
Anaheim 3
Bogotá 3
Chaoyang 3
Clearwater 3
Clifton 3
Corleone 3
Cosenza 3
Totale 9.660
Nome #
Idrocefalo normoteso idiopatico (iNPH): nostra esperienza preliminare. 367
Severe rhabdomyolysis in a patient with “Heat Stroke” 194
MiRNA expression profiling regulates necroptotic cell death in hepatocellular carcinoma 130
PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation. 114
Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment 97
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 93
Prognostic value of HMGB1 and oxidative stress markers in multiple trauma patients: A single-centre prospective study 93
miRNA regulation of Sirtuin-1 expression in human astrocytoma 88
Hippo signaling pathway is altered in Duchenne muscular dystrophy 87
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 85
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 84
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 82
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 80
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 79
MicroRNA signatures predict dysregulated Vitamin D receptor and calcium pathways status in Limb Girdle muscle dystrophies (LGMD) 2A/2B. 79
Circulating miRNAs expression as potential biomarkers of mild traumatic brain injury 79
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma 79
Role of inflammation and oxidative stress mediators in gliomas. 76
null 76
NLRP3 inflammasome CSF expression and neuropsychological changes in idiopathic normal pressure hydrocephalus 76
4-Methyl umbelliferone effects on cell proliferation in human glioma cells. 75
The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice. 75
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 74
Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination 73
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 73
Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation. 72
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC: possibili implicazioni cliniche e prognostiche nei gliomi cerebrali diffusi di basso grado 72
A Nouvel serum MicroRNA signature to screen ATTR 72
ANT1 expression and RAGE-NF-kB pathway activation in sporadic inclusion-body myositis 71
Espressione differenziale di un panel di miRNA in tumori cerebrali astrogliali con diverso grado di malignità. 71
Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination 70
Miopatie metaboliche 69
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC nei gliomi cerebrali diffusi di basso grado: possibili implicazioni cliniche e prognostiche. 69
Effect of exercise on telomere length and telomere proteins expression in mdx mice 68
null 67
NF-kB blockade reduces skeletal muscle degeneration and enhances muscle function in mdx mice. 67
Pilot study of flavocoxid in ambulant DMD patients. 67
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 67
Studio dell'espressione genica del muscolo scheletrico in pazienti affetti da glicogenosi II 66
Autoimmunity to heterogeneous nuclear ribonucleoprotein A1 in psoriatic patients and correlation with disease severity 66
Expression of the tumor necrosis factor receptor-associated factors I and 2 and regulation of the nuclear factor-kappa B antiapoptotic activity in human gliomas 66
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 66
Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy 65
Modulazione della lunghezza telomerica nei diversi gradi di tumore astrogliale nell'uomo. 65
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 65
Detection of αII-Spectrin and Breakdown Products in Humans After Severe Traumatic Brain Injury 64
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy. 64
Matrix Metalloproteinase 9 and Transglutaminase 2 Expression at the Ocular Surface in Patients with Different Forms of Dry Eye Disease 64
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 64
EFFECT OF TREATMENT WITH PDTC AND IRFI 042 ON STRENGTH AND FATIGUE IN MDX MICE 63
Dyscondrosteosis in a child with Becker muscular dystrophy: an unreported association between Xp21 gene (DMD/BMD) deletion and a novel homozygous SHOX gene mutation 63
Type I Hyperprolinemia Associated with Epilepsy and Mental Retardation Results from PRODH Gene Mutations in Three Sicilian Children. 63
Meccanismi antiapoptotici nf-kb-mediati in gliomi umani in vivo. 63
Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification 63
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 62
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 62
VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice 62
A cytochemical study of apoptosis in metabolic myopathies 62
Pilot study of flavocoxid in ambulant DMD patients. 62
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 61
RAGE, NF-kB and oxidative stress: role in FSHD pathogenesis. 60
Evidence of calpain and caspase-3-like activation in CSF of severe human traumatic brain injury 60
Novel SHOX Gene Mutation in a Short Boy with Becker Muscular Dystrophy: Double Trouble in Two Adjacent Genes. 60
Expression of transglutaminase in myopathies 59
Activation of nuclear factor-kappa B in inflammatory myopathies and Duchenne muscular dystrophy 59
Meccanismi anti-apoptotici nei gliomi. Ruolo dell'attività nucleare del nuclear factor-kb e dei suoi fattori di controllo. 59
Ruolo patogenetico dei microRNAs nelle calpainopatie 59
MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation 59
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 58
Ant1 expression and RAGE-NF-kB pathway activation in sporadic inclusion body myositis 57
Expression of telomeric repeat binding factor-1 in astroglial bran tumors 56
Dystrophin gene and SHOX gene mutations in a child with Becker muscular dystrophy and short stature 56
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 56
Calpain 3 deficiency in Quail Eater's disease 56
Analysis of lipid profile in lipid storage myopathy 56
ANT1 is reduced in sporadic inclusion body myositis. 56
Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency 55
Ruolo della proteolisi dell'alfa spectrina nei pazienti affetti da trauma cranico grave 55
Fatal R631C mutation is also present in the adult form of CPTII deficiency 55
Inverse correlation between TRF-1 (telomeric-repeat binding factor 1) and histological grade of malignant brain tumors 55
Myoadenilate deaminase deficiency: clinical, histochemical and biochemical studies in primary and coincidental cases. 55
Telomere length modulation in astroglial brain tumors 55
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 55
Expression of transglutaminase in myopathies 54
Immunohistochemical analysis of human skeletal muscle AMP deaminase deficiency. Evidence of a correlation between the muscle HPRG content and the level of the residual AMP deaminase activity 54
A life threatening case of β-enolase deficiency 54
Severe rhabdomyolysis in a patient with “Heat Stroke” 54
Sarcoglycans in cerebral cortex of the rat: an immunohistochemical and molecular study. 54
Clinical hetrogeneity and molecular basis of myoadenilate deaminase deficiency 53
Clinical heterogeneity and molecular basis of myoadenilate deaminase deficiency 53
Valutazione dell'influenza del polimorfismo del gene multi-drug resistance 1 (MDR1) e dell'espressione della P-glycoprotein (P-GP) sul decorso clinico e sulla sensibilità al trattamento steroideo nella sindrome nefrosica (SN) 53
Activation and localization of transcription factor NF-KB in peripheral neuropathies of different origin. 53
Telomere shortening and telomere associated proteins in exercised wild type and mdx mice. 53
miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors 53
Espressione del telomeric Repeat Binding Factor-1 (TRF-1) nei tumori cerebrali della serie astrogliale: possibili implicazioni clinico-terapeutiche. 53
Human astroglial tumors: transglutaminase 2 and retinoblastoma protein expression 52
Transglutaminase 2 and its short isoform expression in human astroglial brain tumors 52
Pilot study of flavocoxid in ambulant DMD patients. 52
A case of vacuolar myopathy during the course of chronic hepatitis C. 51
Effect of treatment with PDTC and IRFI 042 on strenght and fatigue in mdx mice 51
Totale 7.021
Categoria #
all - tutte 62.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.307


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.377 0 0 0 0 0 193 246 208 54 305 328 43
2020/20211.839 202 27 377 93 221 154 54 178 88 253 115 77
2021/20221.859 14 232 31 72 97 27 141 84 35 237 238 651
2022/20234.537 374 388 233 326 352 432 73 259 1.922 17 109 52
2023/20241.218 90 188 77 95 122 226 39 79 12 96 28 166
2024/20251.076 108 61 114 339 291 163 0 0 0 0 0 0
Totale 14.150